Fed. Circ. Shouldn't Assume Doctors Read Labels, Profs Say

By Dani Kass

The Federal Circuit has been reviewing whether generic-drug companies induce infringement of their limited-use drugs based on a misunderstanding of how prescribing physicians do their job, law professors from Illinois and Pennsylvania have argued in a new paper.

 1 document attached | Read full article » | Save to favorites »